Clinical trial Recruiting at 1 site Observational Ages 18 and up

How illness severity and death risk relate to breathing and limb muscle strength in ICU patients

Official title: Relationship of Disease Severity and Mortality Risk With Respiratory Muscle Strength, Muscle Biomechanical Properties, and Muscle Architecture in Intensive Care Unit Patients

Run by Istinye University · NCT07124442 · Data updated 2026-11-12

This project will see if how sick ICU patients are and their risk of dying are linked to the strength of their respiratory and skeletal muscles for adults in the ICU.

More Critically Ill trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorIstinye University
Academic / other
Locations1 site (Istanbul, Esenyurt)
StatusRecruiting
StartedAugust 15, 2025
Main results expectedSeptember 15, 2025
Study endsOctober 30, 2025
Registry record updatedAugust 15, 2025
Trial IDNCT07124442 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who are monitored in the ICU for at least 48 hours at the study hospital, are not dependent on mechanical ventilation, and can provide consent or have a legal representative to consent.

Probably not a fit

Patients who are mechanically ventilated, have underlying neuromuscular disease, cannot cooperate due to impaired consciousness or communication, or have skin lesions at measurement sites are unlikely to benefit from this observational data collection.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling adult ICU patients monitored for at least 48 hours to measure illness severity scores and muscle function without changing clinical care. Investigators will record established severity measures (for example APACHE II) alongside tests of respiratory and peripheral muscle strength and physical function where patients can cooperate. Patients with neuromuscular disease, inability to consent or cooperate, or skin lesions at measurement sites are excluded. The single-site study is conducted at Istinye University Bahçeşehir Liv University Hospital in Istanbul and follows patients during their ICU stay to describe relationships between severity, mortality risk, and muscle function.

Why it matters

Potential benefit: If successful, the findings could help clinicians identify ICU patients at higher risk of prolonged muscle weakness so they can target monitoring and early rehabilitation.

How similar studies have gone: Prior observational studies have reported links between greater illness severity and ICU-acquired muscle weakness, though using routine severity scores to predict individual outcomes has produced variable results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Not dependent on mechanical ventilation,

Patient or legal representative provides consent to participate,

Aged 18 years or older,

Monitored in the ICU for at least 48 hours.

Exclusion Criteria:

Unable to obtain ethical consent,

Presence of neuromuscular disease affecting muscle tone,

Patients unable to cooperate during measurement due to impaired consciousness, communication disorder, or other medical reasons,

Presence of infection, open wound, or any lesion impairing skin integrity at the anatomical measurement site.

Where it's running

  • Istinye University Bahçeşehir Liv University Hospital
    Istanbul, Esenyurt, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.